Physician profile
Edward Vasquez
NPI 1467114470
$15,540.93
in general payments reported to CMS, 2019-2025
38 companies · $8,035 in 2025
The $8,035 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $1,676 · 2023: $2,217 · 2024: $3,484 · 2025: $8,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $2,127 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,336.13 |
| Travel and Lodging | $2,127.10 |
| Education | $272.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,448.78 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $1,990.31 | 2021-2025 | Breztri, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $1,303.48 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,044.04 | 2021-2025 | Dupixent |
| Genzyme Corporation | $971.56 | 2022-2025 | |
| Regeneron Pharmaceuticals, INC. | $573.74 | 2024-2025 | Dupixent |
| Amgen INC. | $553.51 | 2022-2025 | Tezspire |
| Insmed, INC. | $537.48 | 2023-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $532.40 | 2021-2025 | Glassia |
| Grifols USA, LLC | $410.41 | 2022-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $392.12 | 2024-2025 | Opsumit, Uptravi |
| Baxter Healthcare | $342.34 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $317.35 | 2022-2025 | |
| Harmony Biosciences LLC | $312.77 | 2022-2025 | Wakix |
| Mylan Specialty L.P. | $305.56 | 2022-2024 | Yupelri |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $295.57 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $272.23 | 2025 | Yupelri |
| Boston Scientific Corporation | $226.13 | 2022-2024 | Exalt Model D |
| Vifor Pharma, INC. | $206.49 | 2024-2025 | Zemaira |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.10 | 2022-2025 | Ofev |
| Novartis Pharmaceuticals Corporation | $185.86 | 2022-2024 | |
| Electromed, INC. | $176.83 | 2023-2025 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $150.28 | 2023-2025 | Lumryz |
| Zoll Respicardia, INC. | $143.00 | 2025 | Remede System |
| Ars Pharmaceuticals Operations, INC. | $119.72 | 2025 | Neffy |
| United Therapeutics Corporation | $103.10 | 2022-2025 | Tyvaso, Tyvaso |
| Philips North America LLC | $72.32 | 2022-2025 | Patient Interface Software, Vest Therapy Und |
| Ani Pharmaceuticals, INC. | $55.64 | 2025 | Purified Cortrophin Gel |
| Ethicon INC. | $54.35 | 2022-2025 | Monarch Platform |
| Inogen, INC. | $54.05 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $51.34 | 2021 | |
| Csl Behring | $32.73 | 2025 | Hizentra |
| Pfizer INC. | $32.08 | 2025 | |
| Optinose US, INC. | $24.35 | 2025 | |
| Lilly USA, LLC | $15.93 | 2025 | Zepbound |
| Fisher & Paykel Healthcare INC | $14.01 | 2025 | Fisher & Paykel Healthcare |
| Azurity Pharmaceuticals, INC. | $13.58 | 2025 | Alvesco |
| Pinnacle Biologics, INC | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.